Intravenous Lipid Emulsion Therapy

2012 ◽  
pp. 1301-1302
Author(s):  
G. Citerio ◽  
C. Giussani ◽  
Hugo Sax ◽  
Didier Pittet ◽  
Xiaoyan Wen ◽  
...  
Keyword(s):  
Lipid Emulsion ◽  
Intravenous Lipid Emulsion

The use of intravenous lipid emulsion therapy in acute methamphetamine toxicity

2016 ◽  
Vol 34 (8) ◽  
pp. 1732.e3-1732.e4 ◽  
Author(s):  
James Tse ◽  
Kevin Ferguson ◽  
K. Scott Whitlow ◽  
Karly Erickson
Keyword(s):  
Lipid Emulsion ◽  
Intravenous Lipid Emulsion

Intravenous Lipid Emulsion as Salvage Treatment for Haloperidol Toxicity

2020 ◽  
Vol 28 (5) ◽  
pp. e612-e614
Author(s):  
Mohammed T. Awad ◽  
Mujahed Alkhathlan ◽  
Samantha L. Spetz ◽  
Michael Conley ◽  
Ragheb Assaly
Keyword(s):  
Lipid Emulsion ◽  
Salvage Treatment ◽  
Intravenous Lipid Emulsion

Low‐dose intravenous lipid emulsion as a safe treatment for lipophilic intoxications in five cats

2018 ◽  
Vol 6 (4) ◽  
Author(s):  
Marco Pelizzola ◽  
Clara Mattavelli ◽  
Roberta Troìa ◽  
Elsa Murgia ◽  
Massimo Giunti
Keyword(s):  
Lipid Emulsion ◽  
Low Dose ◽  
Safe Treatment ◽  
Intravenous Lipid Emulsion

Intravenous lipid emulsion prolongs survival in rats intoxicated with digoxin

2016 ◽  
Vol 34 (6) ◽  
pp. 1112-1116 ◽  
Author(s):  
Bülent Serhan Yurtlu ◽  
Şule Özbilgin ◽  
Derya Arslan Yurtlu ◽  
Nilay Boztaş ◽  
Gonca Kamacı ◽  
...  
Keyword(s):  
Lipid Emulsion ◽  
Intravenous Lipid Emulsion

Intravenous lipid emulsion entraps amitriptyline in blood and may lower its brain concentration in pigs

2013 ◽  
Vol 30 ◽  
pp. 3-3
Author(s):  
J. Heinonen ◽  
E. Litonius ◽  
J. T. Backman ◽  
P. J. Neuvonen ◽  
P. H. Rosenberg
Keyword(s):  
Lipid Emulsion ◽  
Brain Concentration ◽  
Intravenous Lipid Emulsion

scholarly journals Resolution of Severe Neurologic Signs Following Intravenous Lipid Emulsion Therapy in a Young Dog With a Portosystemic Shunt: Case Report

2021 ◽  
Vol 8 ◽  
Author(s):  
Amanda M. Spillane ◽  
Jenica L. Haraschak ◽  
Maureen A. McMichael
Keyword(s):  
Hepatic Encephalopathy ◽  
Lipid Emulsion ◽  
Reference Interval ◽  
Ammonia Concentration ◽  
Acute Onset ◽  
Portosystemic Shunt ◽  
Dramatic Improvement ◽  
Intravenous Lipid Emulsion ◽  
Life Threatening ◽  
Patient’S History

A 5-month-old male intact Great Pyrenees was presented for an acute onset of severe neurologic signs (stupor, absent menace, intermittent head turn to the left). The patient's history included possible naproxen ingestion with a maximum ingested dose of 59 mg/kg, exceeding the reported dose of >50 mg/kg known to cause neurologic signs. Blood sampling for baseline bloodwork was performed, and intravenous lipid emulsion (ILE) was subsequently administered, for treatment of the suspected toxicosis. Due to severe and life-threatening neurologic signs, other methods of decontamination were contraindicated and unlikely to be effective; extracorporeal therapy was also unavailable. Complete resolution of neurologic signs occurred 30 min after completion of ILE therapy. At this time, the owners found the missing naproxen tablets after returning home and the bloodwork results returned revealing findings consistent with hepatic encephalopathy. The fasted blood ammonia concentration immediately prior to ILE administration was 702.1 μg/dL (reference interval, RI: 24–36 μg/dL) and decreased to 194.1 μg/dL 24 h later. In the first 24 h, the patient also received three doses of lactulose, N-acetylcysteine, and intravenous fluids. The patient was subsequently diagnosed with a single, large intrahepatic portosystemic shunt via computed tomography and underwent an endovascular coil embolization procedure. Given the rapid and dramatic improvement in severe neurologic signs after ILE therapy alone, it is strongly suspected that this treatment resulted in improvement of hepatic encephalopathy.

scholarly journals Intravenous Lipid Emulsion During Heart Transplantation

2021 ◽  
Author(s):  
Frederick C. Cobey ◽  
Masashi Kawabori ◽  
Roman Schumann ◽  
Gregory Couper ◽  
Iwona Bonney ◽  
...  
Keyword(s):  
Heart Transplantation ◽  
Lipid Emulsion ◽  
Intravenous Lipid Emulsion

Management of severe bupropion poisoning with intravenous lipid emulsion

2017 ◽  
Vol 56 (1) ◽  
pp. 51-54 ◽  
Author(s):  
Neeraj Chhabra ◽  
Carol DesLauriers ◽  
Michael Wahl ◽  
Sean M. Bryant
Keyword(s):  
Lipid Emulsion ◽  
Intravenous Lipid Emulsion

Pulmonary Vascular Lipid Deposition After Administration of Intravenous Fat to Infants

PEDIATRICS ◽  
1987 ◽  
Vol 79 (1) ◽  
pp. 99-102
Author(s):  
Robert J. Shulman ◽  
Claire Langston ◽  
Richard J. Schanler
Keyword(s):  
Risk Factor ◽  
Lipid Emulsion ◽  
Clinical Course ◽  
Serum Triglyceride ◽  
Peak Serum ◽  
Lipid Deposition ◽  
Fat Emulsion ◽  
Intravenous Fat Emulsion ◽  
Intravenous Lipid Emulsion ◽  
The Relationship

The incidence of pulmonary vascular lipid deposits in infants who did or did not receive intravenous lipid emulsion was determined through a review of the pulmonary histopathology and clinical course of 39 neonates who died during a two-year period. The relationship between pulmonary vascular lipid deposits and the duration and amount of administered intravenous fat emulsion was assessed. In addition, the effect of monitored serum triglyceride levels on the development of pulmonary vascular lipid deposits was evaluated. The incidence of pulmonary vascular lipid deposits was greater in the group that received intravenous fat emulsion (P < .02). Both the amount (grams per kilogram per day) and duration (days) of intravenous fat emulsion infusion were correlated positively with severity (P < .05) in infants who had pulmonary vascular lipid deposits. No relationship was seen between peak serum triglyceride levels, the frequency of elevated triglycerides, and pulmonary vascular lipid deposits. Although administered fat emulsion was a risk factor for the development of pulmonary vascular deposits, two of 13 infants who had not received intravenous fat emulsion had such deposits.

Sign in / Sign up

Export Citation Format

Share Document